Effects of ovariectomy on trabecular structures of rat alveolar bone.
An association between postmenopausal osteoporosis and tooth loss has been proposed. However, histomorphometrical changes in alveolar bone following estrogen deficiency are rarely reported with data on microtrabecular structural changes. To clarify the relationship between estrogen deficiency and tooth loss, we histomorphometrically analyzed the trabecular structural changes of mandibular alveolar bone in ovariectomized rats. Twenty-four adult female Fischer rats were used. Eight rats were sacrificed on day 0 (baseline). The remaining 16 rats were divided into two groups. One group was ovariectomized bilaterally (OVX) and the other group was subjected to sham surgery (Sham). After administration of tetracycline and calcein, the animals were sacrificed 60 days after surgery. Bone histomorphometry, node-strut analysis and measurement of thickness of alveolar bone proper were performed on the interradicular septum of the first molar on the sagittal surface. The trabecular bone volume and trabecular number of the OVX group were significantly lower than those of the baseline and Sham groups. All of the bone resorptive and formative parameters of the OVX group were significantly higher (about one-and-a-half times) than those of the Sham group. Several osteoclasts were seen lining the irregular, eroded surface facing the bone marrow in the OVX group. Furthermore, the OVX group tended to have low microtrabecular stiffness and showed significantly thinner distal alveolar bone proper than in the baseline and Sham groups. In summary, estrogen deficiency caused osteoporotic changes and thin alveolar bone proper in the interradicular septum of rat first molar. This phenomenon might accelerate destruction of alveolar bone and tooth loss, especially in elderly women affected by periodontal disease.
Tanaka
M
M
Department of Removable Prosthodontics, Faculty of Dentistry, Niigata University, Japan. mikako@dent.niigata-u.ac.jp
Ejiri
S
S
Toyooka
E
E
Kohno
S
S
Ozawa
H
H
D000539:Alveolar Process / Q000473:pathology* / Q000503:physiopathology; D000704:Analysis of Variance; D000818:Animals; D015519:Bone Density / Q000502:physiology; D001853:Bone Marrow / Q000473:pathology; D016723:Bone Remodeling / Q000502:physiology; D001862:Bone Resorption / Q000473:pathology / Q000503:physiopathology; D004195:Disease Models, Animal; D004967:Estrogens / Q000172:deficiency; D005260:Female; D005452:Fluoresceins; D005456:Fluorescent Dyes; D008334:Mandible / Q000473:pathology; D018613:Microscopy, Confocal; D008963:Molar; D010010:Osteoclasts / Q000473:pathology; D010024:Osteoporosis / Q000473:pathology / Q000503:physiopathology; D010052:Ovariectomy; D010053:Ovary / Q000502:physiology*; D051381:Rats; D011916:Rats, Inbred F344; D013223:Statistics as Topic; D013752:Tetracycline
D004967:Estrogens; D005452:Fluoresceins; D005456:Fluorescent Dyes; D013752:Tetracycline; C007740:fluorexon